|
|
Post by daduke38 on Oct 1, 2014 8:43:04 GMT -5
This is making no sense what so ever! From a thread on another board, is it possible SNY is accumulating for a total buyout? Nothing about the volume and direction makes sense.
Any theories?
|
|
|
|
Post by notamnkdmillionaire on Oct 1, 2014 8:57:00 GMT -5
This is making no sense what so ever! From a thread on another board, is it possible SNY is accumulating for a total buyout? Nothing about the volume and direction makes sense. Any theories? Makes a lot of sense. There is nothing to make anyone want to accumulate here. It is dead money until early or mid 2015. As such, the price will continue to drift down until it finds some support level. Where that is, is anyone's guess right now. Things could change if the company releases some news about developments of another drug etc but I doubt that will happen. I am as disappointed as you are but the reality is that MNKD will only shine once Afrezza shows that it is successful based on sales figures. Once ANALysts realize that they really never understood that Afrezza is not Exubera and that diabetics love it will MNKD start to take off. That is assuming Sanofi doesn't buy it out before that point. |
|
|
|
Post by mdcenter61 on Oct 1, 2014 8:58:20 GMT -5
My theory yesterday was little or low volume, very few actual shares being sold, and that those shares were being bought by SNY. Today, not so sure!
The silence from management is deafening and quite frankly, very infuriating. It is difficult to keep standing here as a long and continue to take punches. Utter BS - and no, I am still not selling one share! |
|
|
|
Post by suebeeee1 on Oct 1, 2014 9:03:23 GMT -5
The entire market has been hit hard the last few days. Of course, at $5.70, this has been hit far harder than the average stock. However, I believe in the drug and in the Technosphere technology. I picked some shares up this morning. AND...I have options that will execute in November in which I will be buying shares at a price quite a bit higher than the stock price is now. These will all turn into long term holds.
It will all be good......
|
|
|
|
Post by pmikeks on Oct 1, 2014 10:08:47 GMT -5
I can see the PPS drift down but close to a 5% drop isn't a drift. With the whole market down I'm sure investers are striping their portfolios of dead money and it doesn't get much deader then this. They figure they can buy back in at a very low price maybe $3-$4 range when something happen that management can't stay mum about.
Management could care less about their investors, if the PPS goes to a certain level they will most likely grant themselves more shares. It's been quite some time since any of them have had a 'preplanned sale'. I wonder why. But not really they will continue to take care of themselves while investers are left hanging. Management of any company has a fiduciary responsibility to their investors to maximize shareholder value. Could be legal ramifications if they continue to be stupid. I strongly believe in both Afrezza and technosphere, just wish Mannkind management weren't morons.
|
|
|
|
Post by dreamboatcruise on Oct 1, 2014 10:43:11 GMT -5
My theory yesterday was little or low volume, very few actual shares being sold, and that those shares were being bought by SNY. Today, not so sure!
The silence from management is deafening and quite frankly, very infuriating. It is difficult to keep standing here as a long and continue to take punches. Utter BS - and no, I am still not selling one share! Not to seem too didactic, but if there is no evidence that SNY is buying and no way of testing the idea, it is speculation not a theory. |
|
|
|
Post by suebeeee1 on Oct 1, 2014 10:52:27 GMT -5
They figure they can buy back in at a very low price maybe $3-$4 range when something happen that management can't stay mum about. PLEASE not $3-$4! Geez, after all the good news and the partnership, who would have ever guessed? |
|
|
|
Post by jurystillout on Oct 1, 2014 10:59:14 GMT -5
We are all waiting for the next big event that will drive the price up, however these big events have already happened and all we get is a pop and retreat. The retreat is due to Matt Pfiffer and his total lack of respect for the people that have invested their hard earned money in this company. He feels no need to divulge the information that would sustain the pop's and keep away the shorts. A good example of this would be the lack of transparency regarding the partner ship with SNY.
People are shorting this stock because they believe SNY gave MNKD 150M to put this product on the shelf, with the information that MNKD has provided maybe SNY did?? However, anyone that has ever been in business and has had exclusive distribution for a product (which SNY has) is required to commit to the sale of the product in the form of volume of units, dollars in sales or at minimum, a commitment to spend X$ in marketing and sales. SNY required this commitment from mnkd in the form of milestones, they don't get paid unless they deliver. Why hasn't Matt divulged the commitment that they agreed to with SNY?
We all know that SNY has an exit strategy if they are not successful with mnkd, what is mnkd's exit strategy if SNY doesn't deliver?
If Matt had any appreciation for us longs he would be forthcoming with this info, all we see is the partnership from the SNY perspective, give us both sides of the story! If this agreement is truly this one sided then we are in real trouble, however with Matt leaving all of these details to the imagination of the market we will never see the growth we all anticipated.
I suggest that we all bombard Matt's email account with questions until he starts to open his mouth or we campaign to have Matt fired so he can be replaced with someone that has enough respect for investors to be somewhat accountable.
|
|
|
|
Post by dreamboatcruise on Oct 1, 2014 11:12:57 GMT -5
jurystilloutIf there are terms such as that MNKD gets to back out if sales of $xM don't occur by end of 2015 or 2016, the shorts would simply point to that and say... "look MNKD is concerned that SNY isn't going to even be able to sell such little amount" Hopefully there is some budget commitment for marketing, but if there is I can understand why SNY might want to delay having competition notified. Under that circumstance Matt, or any successor, might well be legally prevented by non-disclosure clauses from talking about it now. I think the real culprit(s) in our share weakness comes from our prior problems with FDA and to whatever extent that is to be blamed on FDA vs management. MNKD became an easy target due to its sordid past. It is simply too easy to create FUD at this point. Perhaps there is something in the agreement that could overpower history and FUD, but I'm far less certain than you that standard terms would accomplish that.
|
|
|
|
Post by kc on Oct 1, 2014 11:34:17 GMT -5
Well I still think that somebody is buying and my guess is SNY. But I was figuring it would be by 12/31 they would own a % like the did with REGN or earlier this year with ALNY. But who really knows. Somebody is buying. Here are blocks over 10,000 shares each just this session.  |
|
|
|
Post by jurystillout on Oct 1, 2014 11:51:05 GMT -5
The shorts can say whatever they want however if real facts are on the table investors can make informed decisions and if these fact are good then the price will reflect it.
If it's a matter of legality, Matt would not be allowed to disclose that SNY has an out and that the Milestones are in place. It's the same information just in reverse, what is SNY's contractual commitment/incentive to produce?
The only thing that will stop all of the BS that's being spewed around are real facts and Matt obviously does not think we deserve them, I think he's wrong!
|
|
|
|
Post by otherottawaguy on Oct 1, 2014 12:16:51 GMT -5
Maybe it is just a couple of us on this board trading out 10000 shares and buying back 10100. Maybe... 
OOG |
|
|
|
Post by kc on Oct 1, 2014 13:24:01 GMT -5
Yep that is how the shorts grind it out trading back and forth a couple of pennies at a time down down down. Maybe it is just a couple of us on this board trading out 10000 shares and buying back 10100. Maybe...
OOG |
|
|
|
Post by mnholdem on Oct 1, 2014 14:20:51 GMT -5
We are all waiting for the next big event that will drive the price up, however these big events have already happened and all we get is a pop and retreat. The retreat is due to Matt Pfiffer and his total lack of respect for the people that have invested their hard earned money in this company. He feels no need to divulge the information that would sustain the pop's and keep away the shorts. A good example of this would be the lack of transparency regarding the partner ship with SNY... If Matt had any appreciation for us longs he would be forthcoming with this info, all we see is the partnership from the SNY perspective, give us both sides of the story! If this agreement is truly this one sided then we are in real trouble, however with Matt leaving all of these details to the imagination of the market we will never see the growth we all anticipated. I suggest that we all bombard Matt's email account with questions until he starts to open his mouth or we campaign to have Matt fired so he can be replaced with someone that has enough respect for investors to be somewhat accountable.
Matt explained (and the 10-Q filed for the 2nd Quarter confirms) that the full Sanofi License Agreement would be filed with the next 10-Q. Considering the HSR review only expired last week, making the deal official, how could anyone have expected Matt to explain details? I hear people say things like "they've had months to work this out." Well, the truth of the matter is... they haven't. Aside from negotiations related to the Licensing and Supply Agreements, they were forbidden from conducting certain activities until they officially became partners.
I really would like to know how you "see the partnership from the SNY perspective" considering that Sanofi has talked about the details of the deal less than Matt has.
Many are frustrated with the dropping pps and feel that the company should be blamed. But, frankly, if I were Matt or Al, after having been sued once by shareholder for "over-promising", I wouldn't tell you anything except events that just occurred or events that I KNOW are about to occur. Especially if any of the other partnership deals in the works involve confidentiality agreements.
There will be SEC filings and conference calls coming soon to explain the deals, including the future of Technosphere drug partnerships, if those partners permit MannKind to divulge the information. In fact, if it weren't for requisite public patent and testing applications, none of us would likely even know the five companies currently being considered for future Technosphere development (I'm betting there are more than those we currently know about).
I, for one, am glad that management has chosen to stay focused on its important activities, rather than trying to "take on" Wall Street hedge fund pundits or for Matt to waste time continuously trying to placate disgruntled shareholders.
|
|
|
|
Post by jurystillout on Oct 1, 2014 16:42:31 GMT -5
Matt has known the content of the partnership agreement before the partnership was announced (I hope), he has more than sufficient time to prepare information regarding the contract for shareholders, when the HSR review expired there should have been more details available.
To your point, Sanofi hasn't given so much as a peep regarding Afrezza. All of the information came from Mannkind however all the information is from the Sanofi perspective. The milestones are perfect example of how Sanofi has insured that Mannkind will live up to there end of the deal, what has Mannkind put in the contract to insure that Sanofi will do the same? Simple question, how can it be legal to tell one side of the story and not the other?
If Matt does not have the capability to provide information without being sued then maybe that's another reason why we need someone else in charge of investor relations.
Please inform me about the date and times of these filings and conference calls, because I'm completely unaware of any announcements to these.
I'm also glad to see management focused on important activities, however I have a different opinion of whats important to me and that is getting real facts regarding the company that I have my money invested in, The Mannkind web site has Matt listed as Investor relations, Part of his job is keeping investors informed (with facts not fluff) and in My opinion Matt is doing a horrible job, and it shouldn't be tolerated.
|
|
